UBS analyst Joshua Spector raised the firm’s price target on FMC (FMC) to $45 from $41 and keeps a Neutral rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC:
- Cautious Hold Rating for FMC Amid Uncertainties and Growth Opportunities
- FMC price target raised to $49 from $48 at Barclays
- FMC announces regulatory approval for Tremisia fungicide in Ukraine
- DoorDash, AMD upgraded: Wall Street’s top analyst calls
- Wells upgrades FMC to Overweight on confidence in earnings bottom